Real-Time, Ultrasensitive, and High-Throughput Monitoring of Adeno-Associated Virus Production via an Aldehyde-Functionalized Dual-Capture MetaSPR Fishing Sensor
简介:
- 作者: Hanlin Zhou, Youqian Chen, Tong Li, Yuhong Li, Jie Li, Yanan Li, Xianchun Zong, Gang Logan Liu, Zhiguo Qin, Liping Huang
- 杂志: Analytical Chemistry
- Doi: https://www.doi.org/10.1021/acs.analchem.5c07077
- 出版日期: 2026/1/20
摘要
Adeno-associated virus (AAV) is a key vector in gene therapy, yet conventional AAV quality control methods are time-consuming and unsuitable for real-time monitoring, severely hindering process optimization. Here, we present an aldehyde-functionalized metasurface plasmon resonance (ALMetaSPR) biosensor for rapid, label-free, and high-throughput AAV quantification. Two complementary platforms were developed: a 96-well high-throughput system enabling analysis within 15 min (8-fold faster than ELISA); and a portable MetaSPR-based process analytical technology (PAT) device (MSPR-PAT) that integrates microfluidics and smartphone interfaces for real-time online monitoring of AAV production. Both platforms can accurately quantify AAV-2 and AAV-5 titers directly without sample labeling. The antibody-based capture system exhibited a broad dynamic range (6.25 × 1009–4.00 × 1011 GC/mL) with a limit of detection (LOD) of 1.24 × 1009 GC/mL, representing a 250-fold sensitivity improvement over current label-free techniques. The biosensor surface can be regenerated more than 42 cycles without performance loss, which significantly reduces the per-test costs. This innovation resolves a critical bottleneck in gene-therapy manufacturing by integrating high-throughput screening, real-time process analytics, and one-step operation.
关于派真
作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IIT、IND及BLA的各个阶段。
凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。